| Reference |
|---|
Aleman J, Ravikumar K, Wiegand C, Schurdak M, Vernetti L, Gavlock D, et al. A metabolic-dysfunction associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system. bioRxiv. 2024;: pubmed publisher |
Moon C, Kim C, Jung J, Cho Y, Choi K, Han K, et al. Integrated Analysis of Transcriptome and Proteome of the Human Cornea and Aqueous Humor Reveal Novel Biomarkers for Corneal Endothelial Cell Dysfunction. Int J Mol Sci. 2023;24: pubmed publisher |
Ishihara R, Oda T, Murakami Y, Matsumura I, Watanabe S, Asao Y, et al. Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. Int J Mol Sci. 2023;24: pubmed publisher |
Tsomidis I, Notas G, Xidakis C, Voumvouraki A, Samonakis D, Koulentaki M, et al. Enzymes of Fibrosis in Chronic Liver Disease. Biomedicines. 2022;10: pubmed publisher |
Nasiri Ansari N, Spilioti E, Kyrou I, Kalotychou V, Chatzigeorgiou A, Sanoudou D, et al. Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability. Int J Mol Sci. 2022;23: pubmed publisher |
Frey D, Bridson C, Dittrich S, Graeber S, Stahl M, Wege S, et al. Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis. Front Microbiol. 2022;13:885822 pubmed publisher |
Smeda M, Galler K, Woelflick M, Rosendahl A, Moehle C, Lenhardt B, et al. Molecular Biological Comparison of Dental Pulp- and Apical Papilla-Derived Stem Cells. Int J Mol Sci. 2022;23: pubmed publisher |
Huang H, Lin Q, Dai X, Chen J, Bai Z, Li X, et al. Derivation and validation of urinary TIMP-1 for the prediction of acute kidney injury and mortality in critically ill children. J Transl Med. 2022;20:102 pubmed publisher |
Brown Lobbins M, Slominski A, Hasty K, Zhang S, Miller D, Li W, et al. Modulation by 17,20S(OH)2pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis. Int J Mol Sci. 2021;23: pubmed publisher |
Udzik J, Waszczyk A, Safranow K, Biskupski A, Majer K, Kwiatkowski S, et al. Assessment and Prognosis in CSA-AKI Using Novel Kidney Injury Biomarkers: A Prospective Observational Study. Biology (Basel). 2021;10: pubmed publisher |
Moriya K, Nishimura N, Namisaki T, Takaya H, Sawada Y, Kawaratani H, et al. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. J Clin Med. 2021;10: pubmed publisher |
Jarecki J, Małecka Massalska T, Polkowska I, Potoczniak B, Kosior Jarecka E, Szerb I, et al. Level of Adiponectin, Leptin and Selected Matrix Metalloproteinases in Female Overweight Patients with Primary Gonarthrosis. J Clin Med. 2021;10: pubmed publisher |
Sriphoosanaphan S, Thanapirom K, Kerr S, Suksawatamnuay S, Thaimai P, Sittisomwong S, et al. Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial. Peerj. 2021;9:e10709 pubmed publisher |
Waszczykowska A, Podgórski M, Waszczykowski M, Gerlicz Kowalczuk Z, Jurowski P. Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report. Int J Mol Sci. 2020;21: pubmed publisher |
Phillips T, Huitema L, Cepeda R, Cobos D, Perez R, Garza M, et al. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa. J Dermatol Sci. 2020;100:209-216 pubmed publisher |
Rodríguez Sánchez E, Navarro García J, Aceves Ripoll J, Abarca Zabalía J, Susmozas Sánchez A, Bada Bosch T, et al. Variations in Circulating Active MMP-9 Levels During Renal Replacement Therapy. Biomolecules. 2020;10: pubmed publisher |
Stanciu A, Zamfir Chiru Anton A, Stanciu M, Pantea Stoian A, Nitipir C, Gheorghe D. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma. Oncol Lett. 2020;19:3011-3020 pubmed publisher |
Moreno Ajona D, Irimia P, Rodriguez J, Garcia Velloso M, Lopez Fidalgo J, Fernández Alonso L, et al. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study. BMC Cardiovasc Disord. 2020;20:93 pubmed publisher |
Kobus A, Bagińska J, Łapińska Antończuk J, Ławicki S, Kierklo A. Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls. Biomed Res Int. 2019;2019:7420345 pubmed publisher |
Zhang D, Peng Y, Zhang H, Ma J, Zhao M, Yin S, et al. Basilar Artery Tortuosity Is Associated With White Matter Hyperintensities by TIMP-1. Front Neurosci. 2019;13:836 pubmed publisher |
Singh B, Ghosh N, Saha D, Sarkar S, Bhattacharyya P, Chaudhury K. Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study. Pulm Pharmacol Ther. 2019;58:101831 pubmed publisher |
Lorente L, Martín M, Ramos L, Argüeso M, Cáceres J, Sole Violan J, et al. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients. BMC Neurol. 2019;19:167 pubmed publisher |
Matulka M, Konopka A, Mroczko B, Pryczynicz A, Kemona A, Groblewska M, et al. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma. Dis Markers. 2019;2019:3136792 pubmed publisher |
Kunin M, Carmon V, Beckerman P, Dinour D. Effect of Peritoneal Dialysis on Serum Fibrosis Biomarkers in Patients with Refractory Congestive Heart Failure. Int J Mol Sci. 2019;20: pubmed publisher |
Lorente L, Martín M, Ramos L, Argüeso M, Cáceres J, Sole Violan J, et al. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients. J Crit Care. 2019;51:117-121 pubmed publisher |
Liang Z, Lu X, Zhu D, Yi X, Wu F, He N, et al. Ginsenoside Rg1 Accelerates Paracrine Activity and Adipogenic Differentiation of Human Breast Adipose-Derived Stem Cells in a Dose-Dependent Manner In Vitro. Cell Transplant. 2019;28:286-295 pubmed publisher |
Wu C, Su M, Wu Y, Hwang J, Lin L. Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients. J Clin Med. 2018;7: pubmed publisher |
Zajkowska M, Gacuta E, Kozłowska S, Lubowicka E, Głażewska E, Chrostek L, et al. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve. Adv Med Sci. 2019;64:1-8 pubmed publisher |
Mulyadi -, Sunnati -, Azhary M, Yunus F, Nurwidya F. The correlation of age and body mass index with the level of both protease MMP3 and anti-protease TIMP-1 among Indonesian patients with chronic obstructive pulmonary disease: a preliminary findings. BMC Res Notes. 2018;11:551 pubmed publisher |
Nguyen E, Centenera M, Moldovan M, Das R, Irani S, Vincent A, et al. Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived Prostate Tumor Explants. Mol Cell Proteomics. 2018;17:1470-1486 pubmed publisher |
Ruediger C, John B, Kumar S, Lim H, Rangnekar G, Roberts Thomson K, et al. Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. Indian Pacing Electrophysiol J. 2018;18:1-5 pubmed publisher |
Stanciu A, Vatasescu R, Stanciu M, Serdarević N, Dorobantu M. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Cytokine. 2018;103:63-68 pubmed publisher |
Schmalz G, Davarpanah I, Jager J, Mausberg R, Krohn Grimberghe B, Schmidt J, et al. MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study. J Microbiol Immunol Infect. 2019;52:386-394 pubmed publisher |
Lipczyńska M, Szymanski P, Kumor M, Klisiewicz A, Hoffman P. Collagen turnover biomarkers and systemic right ventricle remodeling in adults with previous atrial switch procedure for transposition of the great arteries. PLoS ONE. 2017;12:e0180629 pubmed publisher |
Mailankody S, Dangeti G, Soundravally R, Joseph N, Mandal J, Dutta T, et al. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis. PLoS ONE. 2017;12:e0181262 pubmed publisher |
Gusella M, Bolzonella C, Paolini R, Rodella E, Bertolaso L, Scipioni C, et al. Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia. Tumour Biol. 2017;39:1010428317694325 pubmed publisher |
Niño M, Serrano S, Niño D, McCosham D, Cárdenas M, Villareal V, et al. TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model. PLoS ONE. 2017;12:e0171191 pubmed publisher |
Mieczkowska J, Rutkowska E, Mosiewicz J, Mosiewicz B. Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women. Dis Markers. 2016;2016:7169531 pubmed publisher |
Yang J, Savvatis K, Kang J, Fan P, Zhong H, Schwartz K, et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710 pubmed publisher |
Nalluri S, Ghoshal Gupta S, Kutiyanawalla A, Gayatri S, Lee B, Jiwani S, et al. TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2. PLoS ONE. 2015;10:e0137673 pubmed publisher |
Kmiecik A, Pula B, Suchanski J, Olbromski M, Gomulkiewicz A, Owczarek T, et al. Metallothionein-3 Increases Triple-Negative Breast Cancer Cell Invasiveness via Induction of Metalloproteinase Expression. PLoS ONE. 2015;10:e0124865 pubmed publisher |
Zhao R, Chen N, Zhou X, Miao P, Hu C, Qian L, et al. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model. J Transl Med. 2014;12:330 pubmed publisher |
Thevenard J, Verzeaux L, Devy J, Etique N, Jeanne A, Schneider C, et al. Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE. 2014;9:e103839 pubmed publisher |
Uezumi A, Fukada S, Yamamoto N, Ikemoto Uezumi M, Nakatani M, Morita M, et al. Identification and characterization of PDGFR?+ mesenchymal progenitors in human skeletal muscle. Cell Death Dis. 2014;5:e1186 pubmed publisher |
Lorente L, Martín M, Lopez P, Ramos L, Blanquer J, Cáceres J, et al. Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury. PLoS ONE. 2014;9:e94370 pubmed publisher |
Symeonidis C, Papakonstantinou E, Androudi S, Tsaousis K, Tsinopoulos I, Brazitikos P, et al. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade. Cytokine. 2012;59:184-90 pubmed publisher |
Jaedicke K, Taylor J, Preshaw P. Validation and quality control of ELISAs for the use with human saliva samples. J Immunol Methods. 2012;377:62-5 pubmed publisher |
Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, et al. Prognostic significance of TIMP-1 in non-small cell lung cancer. Anticancer Res. 2011;31:4031-8 pubmed |
Kong M, Li Y, Oster R, Gaggar A, Clancy J. Early elevation of matrix metalloproteinase-8 and -9 in pediatric ARDS is associated with an increased risk of prolonged mechanical ventilation. PLoS ONE. 2011;6:e22596 pubmed publisher |
Geraghty P, Dabo A, D ARMIENTO J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem. 2011;286:30211-8 pubmed publisher |
Jonsson S, Lundberg A, Kälvegren H, Bergström I, Szymanowski A, Jonasson L. Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris. PLoS ONE. 2011;6:e19340 pubmed publisher |
Kluger H, Hoyt K, Bacchiocchi A, Mayer T, Kirsch J, Kluger Y, et al. Plasma markers for identifying patients with metastatic melanoma. Clin Cancer Res. 2011;17:2417-25 pubmed publisher |
Meissburger B, Stachorski L, Roder E, Rudofsky G, Wolfrum C. Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia. 2011;54:1468-79 pubmed publisher |
Symeonidis C, Papakonstantinou E, Androudi S, Rotsos T, Diza E, Brazitikos P, et al. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy. Cytokine. 2011;54:212-7 pubmed publisher |
Hansson J, Vasan R, Arnlov J, Ingelsson E, Lind L, Larsson A, et al. Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS ONE. 2011;6:e16185 pubmed publisher |
Farlow E, Vercillo M, Coon J, Basu S, Kim A, Faber L, et al. A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer. 2010;103:1221-8 pubmed publisher |
Idriss N, Lip G, Balakrishnan B, Jaumdally R, Boos C, Blann A. Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor. Thromb Haemost. 2010;104:1029-37 pubmed publisher |
Katial R, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol. 2010;126:738-44 pubmed publisher |
Mroczko B, Groblewska M, Okulczyk B, Kędra B, Szmitkowski M. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. Int J Colorectal Dis. 2010;25:1177-84 pubmed publisher |
Tolosana J, Mont L, Sitges M, Berruezo A, Delgado V, Vidal B, et al. Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy. Eur J Heart Fail. 2010;12:492-8 pubmed publisher |
Teles R, Teles R, Amadeu T, Moura D, Mendonça Lima L, Ferreira H, et al. High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions. Infect Immun. 2010;78:1012-21 pubmed publisher |
Pitteri S, Jebailey L, Faca V, Thorpe J, Silva M, Ireton R, et al. Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE. 2009;4:e7916 pubmed publisher |
Reikvam H, Hatfield K, Oyan A, Kalland K, Kittang A, Bruserud O. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. Eur J Haematol. 2010;84:239-51 pubmed publisher |
Lorente L, Martín M, Labarta L, Díaz C, Sole Violan J, Blanquer J, et al. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care. 2009;13:R158 pubmed publisher |
Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J, et al. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J Cyst Fibros. 2009;8:338-47 pubmed publisher |
O Kane C, McKeown S, Perkins G, Bassford C, Gao F, Thickett D, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009;37:2242-9 pubmed publisher |
Gogly B, Fournier B, Couty L, Naveau A, Brasselet C, Durand E, et al. Gingival fibroblast inhibits MMP-7: evaluation in an ex vivo aorta model. J Mol Cell Cardiol. 2009;47:296-303 pubmed publisher |
Glass Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210:124-7 pubmed publisher |
Kong M, Gaggar A, Li Y, Winkler M, Blalock J, Clancy J. Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci. 2009;6:9-17 pubmed |
Kapsoritakis A, Kapsoritaki A, Davidi I, Lotis V, Manolakis A, Mylonis P, et al. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterol. 2008;8:55 pubmed publisher |
Castellano G, Malaponte G, Mazzarino M, Figini M, Marchese F, Gangemi P, et al. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res. 2008;14:7470-80 pubmed publisher |
McKeown S, Richter A, O Kane C, McAuley D, Thickett D. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur Respir J. 2009;33:77-84 pubmed publisher |
Huh J, Baek Y, Kim Y, Lee J, Choi D, Park D. Protective effects of butanol fraction from Betula platyphyla var. japonica on cartilage alterations in a rabbit collagenase-induced osteoarthritis. J Ethnopharmacol. 2009;123:515-21 pubmed publisher |
Bendrik C, Robertson J, Gauldie J, Dabrosin C. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008;68:3405-12 pubmed publisher |
Glader P, Eldh B, Bozinovski S, Andelid K, Sjostrand M, Malmhall C, et al. Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space. Eur Respir J. 2008;32:644-50 pubmed publisher |
Nicol G, Han M, Kim J, Birse C, Brand E, Nguyen A, et al. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol Cell Proteomics. 2008;7:1974-82 pubmed publisher |
Huh J, Kim D, Oh Y, Shim T, Lim C, Lee S, et al. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?. Chest. 2008;133:1101-6 pubmed |
Goleva E, Hauk P, Boguniewicz J, Martin R, Leung D. Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol. 2007;120:1065-72 pubmed |
Kellouche S, Martin C, Korb G, Rezzonico R, Bouard D, Benbunan M, et al. Tissue engineering for full-thickness burns: a dermal substitute from bench to bedside. Biochem Biophys Res Commun. 2007;363:472-8 pubmed |
Thrailkill K, Bunn R, Moreau C, Cockrell G, Simpson P, Coleman H, et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care. 2007;30:2321-6 pubmed |
Zhao Z, McCloud B, Fleming R, Klempner M. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem Biophys Res Commun. 2007;358:528-33 pubmed |
Bodet C, Andrian E, Tanabe S, Grenier D. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destr. J Cell Physiol. 2007;212:189-94 pubmed |
Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole A, et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 2006;54:3152-62 pubmed |
Domeij H, Modeer T, Quezada H, Yucel Lindberg T. Cell expression of MMP-1 and TIMP-1 in co-cultures of human gingival fibroblasts and monocytes: the involvement of ICAM-1. Biochem Biophys Res Commun. 2005;338:1825-33 pubmed |
Ko F, Diba C, Roth M, McKay K, Johnson P, Salome C, et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest. 2005;127:1919-27 pubmed |
Simpson J, Scott R, Boyle M, Gibson P. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med. 2005;172:559-65 pubmed |
Rouy D, Ernens I, Jeanty C, Wagner D. Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation. Anal Biochem. 2005;338:294-8 pubmed |
Sagel S, Kapsner R, Osberg I. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol. 2005;39:224-32 pubmed |
Behera A, Hildebrand E, Scagliotti J, Steere A, Hu L. Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect Immun. 2005;73:126-34 pubmed |
Kuyvenhoven J, Molenaar I, Verspaget H, Veldman M, Palareti G, Legnani C, et al. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb Haemost. 2004;91:506-13 pubmed |
Jumper C, Cobos E, Lox C. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med. 2004;98:173-7 pubmed |
Tziakas D, Chalikias G, Hatzinikolaou H, Parissis J, Papadopoulos E, Trypsianis G, et al. Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int J Cardiol. 2003;92:169-75 pubmed |
Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plast Reconstr Surg. 2003;112:1279-86 pubmed |
D Agostino P, Camemi A, Caruso R, Arcoleo F, Cascio A, Dolce A, et al. Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis. Clin Exp Immunol. 2003;134:138-42 pubmed |
Cataldo D, Bettiol J, Noel A, Bartsch P, Foidart J, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest. 2002;122:1553-9 pubmed |
Fireman E, Kraiem Z, Sade O, Greif J, Fireman Z. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin Exp Immunol. 2002;130:331-7 pubmed |
Szamatowicz J, Laudanski P, Tomaszewska I. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod. 2002;17:284-8 pubmed |
